XBiotech Inc.

NASDAQ: XBIT · Real-Time Price · USD
3.20
-0.04 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
3.15
-1.56%
After-hours: Aug 15, 2025, 04:10 PM EDT

XBiotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-38.53M -24.56M -32.9M -17.41M
Depreciation & Amortization
1.75M 1.74M 2.61M 2.65M
Stock-Based Compensation
1.75M 3.26M 5.06M 4.46M
Other Working Capital
-1.17M 1.8M 7.24M 78.65M
Other Non-Cash Items
5.53M -1.89M 3.62M 90K
Deferred Income Tax
n/a -59K -815K -90K
Change in Working Capital
-1.46M 2.72M 7.6M 79.75M
Operating Cash Flow
-30.96M -18.73M -14.82M 69.44M
Capital Expenditures
-1.3M -362K -585K -3.52M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -63.31M n/a
Sales Maturities Of Investments
n/a 61.86M n/a n/a
Other Investing Acitivies
n/a n/a -63.31M n/a
Investing Cash Flow
-1.3M 61.5M -63.89M -3.52M
Debt Repayment
10.25M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -75M
Other Financial Acitivies
200K -9K n/a 8M
Financial Cash Flow
10.45M -9K n/a -67.01M
Net Cash Flow
-27.35M 42.72M -79.68M -383K
Free Cash Flow
-32.27M -19.09M -15.41M 65.92M